X
M.CNMyriadUraCo
$0.26
Canadian Sec
$0.01
4.00%
C3Q.FMyriad Uranium Corp. R
0,159 €
Frankfurt
0,007 €
4,61%
MYRUFMyriad Uranium Corp.
$0.19
OTC Markets OTCQB
$0.0094
5.20%
  • INVESTORS
    • Presentations
      • Investor
      • Millen Mountain
    • Media
    • Articles
    • Factsheet
    • Sedar Filings
      • 2024 AGM Materials
  • PROJECTS
    • Copper Mountain
    • Red Basin
    • Millen Mountain
  • TEAM
  • NEWS
  • CSE: M / FRA: C3Q / OTC: MYRUF
  • INVESTORS
    • Presentations
      • Investor
      • Millen Mountain
    • Media
    • Articles
    • Factsheet
    • Sedar Filings
      • 2024 AGM Materials
  • PROJECTS
    • Copper Mountain
    • Red Basin
    • Millen Mountain
  • TEAM
  • NEWS
  • CSE: M / FRA: C3Q / OTC: MYRUF

Archives

Monthly Archive for: "March, 2025"
By Madison Smith
In News
Posted March 17, 2025

Myriad Uranium Reports Chemical Assays on 20 Copper Mountain Boreholes. Confirmed U3O8 Grades Are 20% Higher on Average than Previously Reported Gamma Grades. Assays also Reveal the Presence of Extensive Uranium Mineralisation That Could Not Be Detected by the Probe, with Potential Positive Implications for Historical Estimates. Large Number of Additional Intervals to Be Sent for Assay

Vancouver, British Columbia--(Newsfile Corp. - March 17, 2025) - Myriad Uranium Corp. (CSE: M) (OTCQB: MYRUF) (FSE: C3Q) ("Myriad" or the "Company") is pleased to announce the results of chemical [...]

READ MORE
  • Myriad Uranium Corp.
  • #600-1090 W. Georgia St. Vancouver, BC V6E 3V7 Canada
  • +1 604 418 2877
  • +1 604 357 1030
  • tlamb@myriaduranium.com
PROJECTS
  • Copper Mountain
  • Millen Mountain
Latest News
  • Myriad Uranium Closes Over-Subscribed Private Placement
  • Myriad Uranium Announces Private Placement
  • Myriad Uranium Reports Final Chemical Assays from Copper Mountain. Grades Up to 60% Higher Than Probe Equivalents, with Positive Implications for Scale and Scope of the Project. Plan of Operations Application Submitted to Drill High Priority Prospects
CORPORATE
  • Management Team and Board of Directors
INVESTORS
  • News
  • Media
  • Articles
  • Stock Information
  • Sedar Filings
  • Disclaimer
Myriad Uranium Corp. © 2024
  • Privacy Policy
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OKPrivacy Policy